Literature DB >> 18083283

The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity.

Ian M Copple1, Christopher E Goldring, Neil R Kitteringham, B Kevin Park.   

Abstract

The metabolic biotransformation of xenobiotics to chemically reactive metabolites can, in some instances, underlie the pathogenesis of certain adverse drug reactions, due to the development of chemical or oxidative stress. In order to guard against such stresses, mammalian cells have evolved multi-faceted, highly-regulated defence systems, one of the most important being that which is regulated by the transcription factor Nrf2. Through regulating the expression of numerous cytoprotective genes, Nrf2 serves as a critical determinant of a cell's capacity to survive, or succumb, to a toxic insult. The aim of this review is to summarise our current understanding of the biochemistry that underlies the Nrf2 defence pathway, and highlight the important role of this transcription factor in the protection against drug-induced toxicity, primarily through the examination of recent investigations that have demonstrated an increased vulnerability to various toxins in animals lacking Nrf2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083283     DOI: 10.1016/j.tox.2007.10.029

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  85 in total

1.  An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance.

Authors:  James W Kaspar; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.

Authors:  Suryakant K Niture; Anil K Jaiswal
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Nrf2, a guardian of healthspan and gatekeeper of species longevity.

Authors:  Kaitlyn N Lewis; James Mele; John D Hayes; Rochelle Buffenstein
Journal:  Integr Comp Biol       Date:  2010-05-06       Impact factor: 3.326

4.  Changes in hepatic gene expression in response to hepatoprotective levels of zinc.

Authors:  Jie Liu; Zhan-Xiang Zhou; Wei Zhang; Matthew W Bell; Michael P Waalkes
Journal:  Liver Int       Date:  2009-03-23       Impact factor: 5.828

Review 5.  Mechanisms of drug-induced liver injury.

Authors:  Liyun Yuan; Neil Kaplowitz
Journal:  Clin Liver Dis       Date:  2013-08-01       Impact factor: 6.126

6.  Different effects of low- and high-dose waterborne zinc on Zn accumulation, ROS levels, oxidative damage and antioxidant responses in the liver of large yellow croaker Pseudosciaena crocea.

Authors:  Jia-Lang Zheng; Lin Zeng; Mei-Ying Xu; Bin Shen; Chang-Wen Wu
Journal:  Fish Physiol Biochem       Date:  2016-08-13       Impact factor: 2.794

7.  Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis.

Authors:  Arwa S Kathiria; Mackenzie A Butcher; Jason M Hansen; Arianne L Theiss
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-14       Impact factor: 4.052

8.  Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells.

Authors:  Megan L Steele; Stacey Fuller; Annette E Maczurek; Cindy Kersaitis; Lezanne Ooi; Gerald Münch
Journal:  Cell Mol Neurobiol       Date:  2012-07-31       Impact factor: 5.046

9.  The role of Nrf1 and Nrf2 in the regulation of copper-responsive transcription.

Authors:  Min Ok Song; Michael D Mattie; Chang-Ho Lee; Jonathan H Freedman
Journal:  Exp Cell Res       Date:  2014-01-23       Impact factor: 3.905

10.  Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor.

Authors:  Masahiro Nomoto; Masaaki Miyata; Shanai Yin; Yasushi Kurata; Miki Shimada; Kouichi Yoshinari; Frank J Gonzalez; Kokichi Suzuki; Shigeki Shibasaki; Tohru Kurosawa; Yasushi Yamazoe
Journal:  Biol Pharm Bull       Date:  2009-02       Impact factor: 2.233

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.